Clinical Trials Browser

Phase 1 × Solid Malignancies × ixabepilone × Clear all

NCT00162136 2020-11-02

Clinical Study of Ixabepilone Administered as a 24 Hour Infusion in Patients With Solid Malignancies.

Phase 1 Completed

35 enrolled 17 charts

Solid Malignancies